1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Hanscom, Thomas, M.D.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab ranibizumab 0.5mg, ranibizumab 1.0mg - Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion | Phase 1 / Phase 2 | Completed | Hanscom, Thomas, M.D. | 14 | 2011-11-01 | 2015-04-29 |
Macular Edema (1) · Retinal Vein Occlusion (1)
Ranibizumab (1)
United States (1)